Chinese english Germany Japanese Korea

ethyl {[3-allyl-4-oxo-3,4,5,6-tetrahydrospiro(benzo[h]quinazoline-5,1'-cyclopentane)-2-yl]sulfanyl}acetate

ethyl {[3-allyl-4-oxo-3,4,5,6-tetrahydrospiro(benzo[h]quinazoline-5,1'-cyclopentane)-2-yl]sulfanyl}acetate Struktur
332024-55-2
CAS-Nr.
332024-55-2
Englisch Name:
ethyl {[3-allyl-4-oxo-3,4,5,6-tetrahydrospiro(benzo[h]quinazoline-5,1'-cyclopentane)-2-yl]sulfanyl}acetate
Synonyma:
ethyl {[3-allyl-4-oxo-3,4,5,6-tetrahydrospiro(benzo[h]quinazoline-5,1'-cyclopentane)-2-yl]sulfanyl}acetate;Acetic acid, 2-[[4-oxo-3-(2-propen-1-yl)spiro[benzo[h]quinazoline-5(3H),1'-cyclopentane]-2(6H)-yl]thio]-, ethyl ester
CBNumber:
CB02028219
Summenformel:
C23H26N2O3S
Molgewicht:
410.53
MOL-Datei:
332024-55-2.mol
Request For Quotation

ethyl {[3-allyl-4-oxo-3,4,5,6-tetrahydrospiro(benzo[h]quinazoline-5,1'-cyclopentane)-2-yl]sulfanyl}acetate Eigenschaften

Siedepunkt:
562.2±60.0 °C(Predicted)
Dichte
1.26±0.1 g/cm3(Predicted)
pka
-2.24±0.20(Predicted)

Sicherheit

ethyl {[3-allyl-4-oxo-3,4,5,6-tetrahydrospiro(benzo[h]quinazoline-5,1'-cyclopentane)-2-yl]sulfanyl}acetate Chemische Eigenschaften,Einsatz,Produktion Methoden

ethyl {[3-allyl-4-oxo-3,4,5,6-tetrahydrospiro(benzo[h]quinazoline-5,1'-cyclopentane)-2-yl]sulfanyl}acetate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ethyl {[3-allyl-4-oxo-3,4,5,6-tetrahydrospiro(benzo[h]quinazoline-5,1'-cyclopentane)-2-yl]sulfanyl}acetate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6350 50
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6178 60
Specs --
 info@specs.net The Netherlands 6835 70
  • ethyl {[3-allyl-4-oxo-3,4,5,6-tetrahydrospiro(benzo[h]quinazoline-5,1'-cyclopentane)-2-yl]sulfanyl}acetate
  • Acetic acid, 2-[[4-oxo-3-(2-propen-1-yl)spiro[benzo[h]quinazoline-5(3H),1'-cyclopentane]-2(6H)-yl]thio]-, ethyl ester
  • 332024-55-2
Copyright 2019 © ChemicalBook. All rights reserved